Weekly injections led to higher opioid abstinence rate, with good infant outcomes ...

Weekly injectable buprenorphine is more effective than daily doses for treating opioid use disorder in pregnancy, with higher ...

Extended-release 7-day injectable buprenorphine was safe and tolerable for most patients who had minimal-to-mild opioid withdrawal, a nonrandomized trial found. Among 100 adult patients with ...

In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder ...

Officials in Hennepin and Ramsey County are using buprenorphine, a medication to treat opiate withdrawals symptoms that affect a growing number of Minnesotans. More cities are taking notice. As a ...

Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...

State laws that ban insurance prior authorization for buprenorphine-a leading medication for opioid use disorder-may not help more patients stay in treatment for the recommended minimum of 180 days, ...

Lev Facher covers the U.S. addiction and overdose crisis. Patients who received higher doses of buprenorphine, a common medication used to alleviate opioid withdrawal and cravings, were less likely to ...

Suboxone (buprenorphine/naloxone) is a prescription oral film that’s used in adults to treat dependence on opioid drugs. There are risks and benefits to consider before taking Suboxone during ...

Patients adherent to SUBLOCADE® for 12 months had 42% lower adjusted non-MOUD medical costs vs. those adherent to other forms of MOUDPatients ...